New success of Aristos in the October 2019 call of the EIC Accelerator!
In the October 2019 call of the EIC Acclerator (formerly called SME Instrument Phase 2), two clients of Aristos have won the grant!
Below, we present a brief description of these two great projects:
1. Multiplex8 +, by the Slovak company MultiplexDX, s.r.o .: A highly accurate breast cancer diagnostic test for effective personalized treatment and assessment of therapy response.
2. Ribati, by the Spanish company AMAPEX: A radically innovative bacterial treatment for recalcitrant industrial wastewater.
We at Aristos are very happy to have helped them to achieve this success and we wish you good luck with your wonderful projects!
Follow us on twitter.